Abstract：Objective To explore the condition of the use of adjuvant drugs in the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (hereinafter referred to as "our hospital") from 2014 to 2016, and to guide rational drug use. Methods The utilization of top 10 adjuvant drugs in the list of consumption sum and defined daily doses (DDDs) in our hospital from 2014 to 2016 were analyzed. Results From 2014 to 2016, the top 10 adjuvant drugs in the list of consumption sum were injections and oral Chinese patent medicines, the varieties were mainly composed of neurotrophic, cardio-cerebrovascular drugs and other Chinese patent medicines. Drugs were more used in the department of cardiovascular medicine, encephalopathy rehabilitation and neurology. In terms of top 10 adjuvant drugs in the list of DDDs, oral Chinese patent medicines rank high. The defined daily cost (DDC) is mainly for injection, and the sequencing ratio (B/A) of these drugs was poor and drug price was high. The incidence of adjuvant drugs induced adverse reaction (ADR) was high, and exceeded 60% for three consecutive years. Conclusion The synchronicity of adjuvant drugs consumption sum and DDDs is good. However, attention should be paid to the overuse of adjuvant drugs and strengthen the monitoring, so as to promote rational drug use.
柳杨 赵红喜. 某中医院2014~2016年辅助用药使用情况分析[J]. 中国医药导报, 2018, 15(9): 130-133.
LIU Yang ZHAO Hongxi. Analysis of the use condition of adjuvant drugs in a traditional Chinese medical hospital from 2014 to 2016. 中国医药导报, 2018, 15(9): 130-133.
2018, Vol. 15 
京公网安备 11010502046598号